Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 CareBusiness Wire • 03/19/25
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't WorriedInvestors Business Daily • 03/10/25
DexCom, Inc. (DXCM) Presents at 46th Annual Raymond James Institutional Investors Brokers Conference (Transcript)Seeking Alpha • 03/04/25
Countdown to DexCom (DXCM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 02/10/25
Prediction: This Top Growth Stock Will Outperform the Market in the Next DecadeThe Motley Fool • 02/03/25